- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/32 - Sulfur atoms
Patent holdings for IPC class C07D 213/32
Total number of patents in this class: 75
10-year publication summary
|
8
|
8
|
6
|
5
|
2
|
4
|
0
|
3
|
4
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4721 |
8 |
| Sumitomo Chemical Company, Limited | 9019 |
4 |
| Dow AgroSciences LLC | 1190 |
4 |
| BASF SE | 21294 |
3 |
| Allergan, Inc. | 2181 |
3 |
| Canbas Co., Ltd. | 20 |
3 |
| General Incorporated Association Pharma Valley Project Supporting Organization | 18 |
3 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 185 |
3 |
| T. Hasegawa Co., Ltd. | 92 |
3 |
| Dow Silicones Corporation | 2092 |
3 |
| The Procter & Gamble Company | 21867 |
2 |
| Mitsubishi Chemical Corporation | 4705 |
2 |
| Ecolab USA Inc. | 5795 |
2 |
| Syngenta Participations AG | 1541 |
1 |
| Massachusetts Institute of Technology | 10228 |
1 |
| The Regents of the University of Michigan | 4962 |
1 |
| President and Fellows of Harvard College | 6076 |
1 |
| The Brigham and Women's Hospital, Inc. | 2282 |
1 |
| Congenia S.r.l. | 4 |
1 |
| The Doshisha | 228 |
1 |
| Other owners | 25 |